Breast cancer is one of the most commonly diagnosed cancers in women [1]. There are well established risk factors for breast cancer, such as genetic alterations, age, family history, life-style, hormone replacement therapy, and obesity [2]. According to the American Cancer Society, more than two thirds of breast cancer at the first diagnosis in women is estrogen receptor (ER)-positive [2]. Extended exposure to estrogen is epidemiologically and experimentally associated with an increased risk of developing breast cancer [1]. This appears to be due to the upregulation of genes involved in breast cell proliferation that is mediated through the estrogen receptor. Development of ER-positive breast cancer depends on estrogen for cell growth. Many environmental chemicals are endocrine disrupters that can mimic the biological functions of estrogen, potentially contributing to the initiation or progression of breast cancer.Among known environmental estrogens, bisphenol A (BPA) is widely used in industry. The National Health and Nutrition Examination Survey (NHANES) during 2003 to 2004 indicates widespread exposure to BPA in the US population [3][4][5]. Since then, there is a temporal trend in decreased exposure to BPA in the United States from 2011 to 2012 [6]. However, in a recent cohort study conducted in the United States, it is concluded that higher exposure to BPA is associated with an increased risk of long-term mortality including cancer [7]. BPA has been well known to have estrogenic activity in animal models and in vitro [8][9][10][11][12]. There is a concern for adverse effects of the exposure to BPA in regards to developmental toxicity for fetuses, infants and children, effects on the mammary gland and early puberty in females, and reproductive toxicities [13][14][15]. Importantly, the health outcomes from environmental exposures are highly complex and variable.Many studies looking at the molecular mechanisms through which BPA is thought to induce breast cancer have shown promising results. However, epidemiological studies aimed to uncover a link between BPA exposure and an increased breast cancer risk have been largely inconclusive. It is difficult to evaluate long term effects of endocrine disruptor exposure via retrospective studies, which lack specificity. Prospective cohort studies can be more specific, but they may take many years to complete. Even still, prospective studies often don't have a sample size large enough to yield significance. Due to the relatively low prevalence of breast cancer incidence within a normal population, correlation can be very hard to